• AAPL 165
  • TSLA 147.05
  • AMZN 174.63
  • MSFT 399.12
  • INTC 34.2
  • EURUSD 1.0661
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NEO /
  3. FH.NEO

Filament Health Corp (FH NEO) stock market data APIs

C$0.05 0(0%) as of April 19, 2024

Filament Health Corp Financial Data Overview

0.05
0.05
-
0.05
0.045
0.035-0.25
10 561 K
211 M
2 131 K
1.118
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'FH',
Type: 'Common Stock',
Name: 'Filament Health Corp',
Exchange: 'NEO',
CurrencyCode: 'CAD',
CurrencyName: 'Canadian Dollar',
CurrencySymbol: 'C$',
CountryName: 'Canada',
CountryISO: 'CA',
OpenFigi: NULL,
ISIN: 'CA31685W1068',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - Specialty & Generic',
}

Filament Health Corp Fundamental Data is available in our Financial Data APIs

  • Net Revenue 2 131 K
  • EBITDA -4 438 474
  • Earnings Per Share -0.03
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Filament Health Corp Earnings via APIs

  • Latest Release 2024-04-02
  • EPS/Forecast NaN

Get Filament Health Corp End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Filament Health Corp latest news via APIs

PharmAla Biotech and Filament Health Announce Release of Second Batch of GMP MDMA Capsules

VANCOUVER, British Columbia, Nov. 15, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”) (CSE:MDMA)(OTCQB:PMBHF), a Canadian biotechnology company dedicated to the research and...
  • API
  • AUSTRALIA
  • CANADIAN STOCK EXCHANGE:MDMA.CN
  • CLINICAL TRIALS
  • CONFERENCE CALLS/ WEBCASTS
  • DRUG DEVELOPMENT
  • DRUG PRODUCT
  • HEALTH
  • MDMA
  • PARTNERSHIPS
  • PHARMALA BIOTECH
  • PSYCHEDELICS

PharmAla Biotech and Filament Health Announce Release of GMP MDMA Capsules

VANCOUVER, British Columbia, April 11, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”) (CSE:MDMA), a Canadian biotechnology company dedicated to the research and development...
  • BIOTECH
  • CANADIAN STOCK EXCHANGE:MDMA.CN
  • CLINICAL
  • DRUG
  • DRUG DEVELOPMENT
  • HEALTH
  • MDMA
  • PARTNERSHIPS
  • PHARMALA BIOTECH
  • PRODUCT / SERVICES ANNOUNCEMENT
  • SPECIAL ACCESS
  • TRIALS
Do you have any questions?
support@eodhistoricaldata.com